Stocks
ANI Pharmaceuticals (ANIP) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 60.7 | 29.1 | -1.68 | 48.1 | 109.3 | 64.0 | ||
| Changes by years, y/y, % | -11% | -52% | -106% | -2 954% | +127% | +9.8% | |||
ANI Pharmaceuticals. EBITDA US GAAP, bln rub
ANI Pharmaceuticals. EBITDA US GAAP, changes, %
ANI Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
ANI Pharmaceuticals (ANIP) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 30.6 | 23.9 | 29.7 | 23.7 | -13.4 | 64.0 | |
| Changes by years, y/y, % | +112% | +23% | +12% | -15% | -144% | |||
| Changes by quarters, q/q, % | +9% | -22% | +24% | -20% | -157% | |||
